The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
$2.97 after hours finish
Finished $2.78 on NASDAQ up 13.47%
So he's expecting earnings of over $400m !!!!!!!
Something afoot here!
What price/mcap if hit?
$2.92 on Nasdaq.
GL.
Back in the Nasdag are flying, I posted in my page earlier, they went over $3 from 2.35 opening
a note .......SVB Leerink Weighs in on Mereo BioPharma Group plc’s FY2020 Earnings (NASDAQ:MREO)
Posted by John Perry on Jun 11th, 2020
Mereo BioPharma Group plc (NASDAQ:MREO) – SVB Leerink issued their FY2020 EPS estimates for Mereo BioPharma Group in a research note issued to investors on Monday, June 8th. SVB Leerink analyst J. Schwartz forecasts that the company will post earnings per share of ($1.13) for the year. SVB Leerink also issued estimates for Mereo BioPharma Group’s FY2021 earnings at ($1.25) EPS, FY2022 earnings at ($1.50) ......
https://zolmax.com/investing/svb-leerink-weighs-in-on-mereo-biopharma-group-plcs-fy2020-earnings-nasdaqmreo/4269996.html
C446m shares (together with all converitble notes transfered to shares) at 37p equals 165m pounds market cap
C300 million shares @ 37p is 100 odd million, Still cheap compared to its peers, in any case raising that sort of capital in this market is fantastic, must have been a very persuasive argument.
Not bought any yet as waiting to release funds.
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:
Mereo BioPharma Group plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
X
An event changing the breakdown of voting rights
N/A
Other (please specify)iii:
N/A
3. Details of person subject to the notification obligationiv
Name
Baker Bros. Advisors LP
City and country of registered office (if applicable)
New York, New York USA
4. Full name of shareholder(s) (if different from 3.)v
Name
Baker Brothers Life Sciences, L.P. and 667, L.P.
City and country of registered office (if applicable)
Delaware USA
5. Date on which the threshold was crossed or reachedvi:
03/06/2020
6. Date on which issuer notified (DD/MM/YYYY):
05/06/2020
7. Total positions of person(s) subject to the notification obligation
trade was from the 5th!
Someone bought 700,000 shares !
Was that a £2m buy or a £2m sell late on Friday?
If you take into consideration the number of new shares issued at 17p and today's sp mph's market cap is already above 200m pounds.
I did my research here, the company has already products which are candidates for phase 3, Novartis is also an investor. Comparing this to its peer, imho the market cap should be at least £50O million.
Woodford Now cleared with Acacia Research now buying their stake. Interesting to note that Acacia Research share price surged over a similar time frame last week to Mereo
https://stocktwits.com/symbol/ACTG
https://www.yourmoney.com/investing/woodford-equity-income-fund-a-step-closer-to-being-wound-up/
Oh well, it's definitely different than yesterday. I'm afraid short term we'll have to face the effects of dilution. Nevertheless long term I wouldn't worry at all.
Just a result of the dilution.
GL.
Link down to 8%
Parmxz thanks thats what im doing
@score, I will wait for a few weeks and see. Mereo is defntly good for longterm, I see occational blips. In last week of Dec 2019, it suddenly rose from 26 to 47 without RNS or concrete news and fell down.
ON NEWS a pound with phase 3 news to start will add all way down if possible buying back my sells
Navicixizamub
and going to see how this plays out.
Gotta feeling something is brewing re news and obviously the investors were convinced in providing funding.
US is very keen on what is building here.
now looking at £1+ to sell.
GL.
NICE while it lasted happy long term imo massive
Clear off traders, and by afternoon we will be blue
I think that the excitement is due to the funding being seen as the key to realising the potential of setrusumab for brittle bone disease.
Clearly those institutions & individuals participating in the funding have been convinced. Setrusumab could be a company maker.
To be honest me neither, truffle. I went to work after reading the rns and when I first checked at 2pm I couldn't believe it was 30% up but then I kept checking every 15 minutes which I never do. Couldn't do my job properly , ha ha. Something unbelievable.